NFE2L2 and prostate carcinoma: Notably, prostate cancer-associated SPOP mutations have been found to enhance autophagy and activate the NFE2L2/NRF2 pathway, crucial in managing oxidative stress, by directly modulating sequestosome1 (SQSTM1) LLPS and ubiquitination 96.